NVO
Novo-Nordisk A/S
stockNYSEADR
Market OpenOct 5, 2026 1:25:11 PM EDT
37.19USD-0.362%(-0.13)6,609,046
37.18Bid37.19Ask0.01SpreadPre-marketOct 5, 2026 9:29:56 AM EDT
36.90USD-1.125%(-0.42)
Loading…
Loading…
164.15B
Healthcare
Biotechnology
HQ
Bagsvaerd, Bagsvaerd, Denmark
57,089
Previous Close
$37.32
Beta
1.05
52-Week High
$64.16 2026-01-23
52-Week Low
$35.12 2026-03-30
SMA 50
$44.68
SMA 200
$45.65
Avg. Vol 10D
18.77M
Avg. Vol 30D
12.90M
Avg. Vol 90D
12.62M
Relative Vol
0.44
4.42B
3.17B
71.86%
26,339,706
0.83%
2.92
55%/45%
50.35%
32.28%
0.3300%
10,000,000
13,000
149,184
637,798
Nov 4, 2026 (30d)
Mar 31, 2025 · $1.099
Sep 20, 2023 · 2-for-1
Oct 5, 2026
Novo Nordisk A/S – Share repurchase programme · 
GlobeNewswire Inc.
Oct 4, 2026
Better High-Yield Dividend Stock: Pfizer or Novo Nordisk? · 
The Motley Fool
Oct 2, 2026
Anthropic funds $100M academy to train deployed AI engineers · 
Business Insider
NVO Profile
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.
NVO Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 38.71 | 2026-09-28 | -3.97% | 0.832 |
| 1M | 46.60 | 2026-09-04 | -20.23% | -0.390 |
| 3M | 49.26 | 2026-07-06 | -24.53% | -0.300 |
| 6M | 36.67 | 2026-04-06 | +1.38% | 0.231 |
| 1Y | 59.65 | 2025-10-06 | -37.68% | 1.046 |
| 2Y | 115.12 | 2024-10-04 | -67.71% | — |
| 5Y | 48.72 | 2021-10-05 | -23.69% | 0.673 |
NVO Stock Summary
Novo-Nordisk A/S (NYSE:NVO) stock price today is $37.17, and today's volume is 5,678,305. NVO is down 0.390% today. The 30 day average volume is 12.90M. NVO market cap is $164.15B with 4.42B shares outstanding.